DULAC EDWARD J III (EVP, Chief Financial Officer) sold 5.2% of their position (8.11K shares) of INTELLIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $91.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/24/2026ACC: 0001193125-26-316279
Officer· EVP, Chief Financial Officer
Since Mar 2026
-8.11K
Net shares
Net seller
$91.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.11K
Price / share
$11.25
Trade value
$91.25K
% of position
5.2%
7/22/2026
156.29K→148.18K
Total
Net shares
−8.11K
Net value
-$91.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/22/2026 | S · Sale | −8.11K | $11.25 | $91.25K | 5.2% | 156.29K | 148.18K |
| Total | −8.11K | -$91.25K | ||||||
Derivative Transactions0
No derivative transactions reported